Results 281 to 290 of about 387,780 (352)

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer   +14 more
wiley   +1 more source

Investigation of gut microbiota disorders in norovirus infected children patients based on 16s rRNA sequencing. [PDF]

open access: yesAnn Med
Li J   +8 more
europepmc   +1 more source

Provincial export cost implications of the EU Carbon Border Adjustment Mechanism on China's metal industry. [PDF]

open access: yesiScience
Pan X   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy